The Lancet HIV in conversation with

Author: The Lancet Group

Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journals authors, explore their latest research and its impact on peoples health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Be a guest on this podcast

Language: en-gb

Genres: Health & Fitness, Life Sciences, Medicine, Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial
Episode 2
Wednesday, 29 April, 2026

Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than people without HIV. Esteban Martinez from the Hospital Clinic and University of Barcelona, and Steven Grinspoon from the Massachusetts General Hospital and Harvard Medical School, join us to explore the importance of NCDs and how data from the REPRIEVE trial can help us understand and prevent the underlying causes increasing the risk of NCDs in people with HIV. Click here to read the full articles: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00031-7/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00354-6/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00036-6/fulltext